Introduction and Objectives: Bladder cancer is characterized by gender-dependent disparities. To further address this issue, we analysed a prospective, multicentre cystectomy registry. Methods: An online database was developed that included patient demographics, intra/perioperative data, surgical data and in-house complications. Results: Four hundred fifty-eight patients (112 [24.5%] women and 346 [75.5%] men) were analysed. Men and women were comparable regarding age (mean 68 years), body mass index (mean 26.5) and the mean Charlson score (4.8). Women had more advanced tumour-stages (pT3/pT4; women: 57.1%; men: 48.1%). The rate of incontinent urinary diversion was higher in women (83.1%) than in men (60.2%) and in a multivariate analysis, the strongest predictors were M+ status (OR 11.2), female gender (OR 6.9) and age (OR 6.5). Women had a higher intraoperative blood transfusion rate. The overall rate of in-house complications was similar in both genders (men: 32.0%, women: 32.6%). Severe (Clavien-Dindo grade >2) medical (women: 6.3%; men: 5.2%) and surgical (women: 21.5%; men: 14.4%) in-house complications, however, were more frequent in women. Conclusions: This multicentre registry demonstrates several gender-related differences in patients undergoing radical cystectomy. The higher transfusion rate, the rare use of orthotopic bladder substitutes and the higher in-house complication rate underline the higher complexity of this procedure in women.

Keywords:
Bladder cancer, Invasive, Radical treatment, Urinary diversion, Complications
1.
Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, et al: Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 2011;29:457-463.
2.
Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, et al: Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol 2016;69:300-310.
3.
Wolff I, Brookman-May S, May M: Sex difference in presentation and outcomes of bladder cancer: biological reality or statistical fluke? Curr Opin Urol 2015;25:418-426.
4.
Siegel RL, Miller KD, Jemal A: Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29.
5.
Mungan NA, Kiemeney LA, van Dijck JA, van der Poel HG, Witjes JA: Gender differences in stage distribution of bladder cancer. Urology 2000;55:368-371.
6.
Stenzl A, Cowan NC, De Santis M, et al: Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011;59:1009-1018.
7.
Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagaloswky AI, Soloway MS, Stenzl A; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012: ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2013;63:45-57.
8.
Froehner M, Brausi MA, Herr HW, Muto G, Studer UE: Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 2009;56:443-454.
9.
Lee KL, Freiha F, Presti JC Jr, Gill HS: Gender differences in radical cystectomy: complications and blood loss. Urology 2004;63:1095-1099.
10.
Novara G, De Marco V, Aragona M, Boscolo-Berto R, Cavalleri S, Artibani W, Ficarra V: Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 2009;182:914-921.
11.
Kluth LA, Rieken M, Xylinas E, Kent M, Rink M, Roupret M, et al: Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol 2014;66:913-919.
12.
Scosyrev E, Noyes K, Feng C, Messing E: Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 2009;115:68-74.
13.
Waldhoer T, Berger I, Haidinger G, Zielonke N, Madersbacher S: Sex differences of ≥ pT1 bladder cancer survival in Austria: a descriptive, long-term, nation-wide analysis based on 27,773 patients. Urol Int 2015;94:383-389.
14.
Scosyrev E, Trivedi D, Messing E: Female bladder cancer: incidence, treatment, and outcome. Curr Opin Urol 2010;20:404-408.
15.
Svatek RS, et al: Evidence-based gender related outcomes after radical cystectomy: results of a large multicenter study. J Urol 2009;181:629.
16.
Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S: Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Urol Oncol 2014;32:52:e1-e9.
17.
Garg T, Pinheiro LC, Atoria CL, Donat SM, Weissman JS, Herr HW, Elkin EB: Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. J Urol 2014;192:1072-1077.
18.
Henning A, et al: Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int 2013;112:66-73.
19.
Aziz A, Madersbacher S, Otto W, Mayr R, Comploj E, Pycha A, et al: Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study. Urol Int 2015;94:37-44.
20.
Siegrist T, Savage C, Shabsigh A, Cronin A, Donat SM: Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology. Urol Oncol 2010;28:112-117.
21.
Lavallee LT, Schramm D, Witiuk K, Mallick R, Fergusson D, Morash C, Cagiannos I, Breau RH: Peri-operative morbidity associated with radical cystectomy in a multicenter database of community and academic hospitals. PLoS One 2014;9:e111281.
22.
Gore JL, Litwin MS; Urologic Diseases in America Project: Quality of care in bladder cancer: trends in urinary diversion following radical cystectomy. World J Urol 2009;27:45-50.
23.
Gore JL, Saigal CS, Hanley JM, Schonlau M, Litwin MS; Urologic Diseases in America Project: Variations in reconstruction after radical cystectomy. Cancer 2006;107:729-737.
24.
Kim SP, Shah ND, Weight CJ, Thompson RH, Wang JK, Karnes RJ, Han LC, Ziegenfuss JY, Frank I, Tollefson MK, Boorjian SA: Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer. BJU Int 2013;112:478-484.
25.
Schmid M, Rink M, Traumann M, Bastian PJ, Bartsch G, Ellinger J, et al: Evidence from the ‘PROspective MulticEnTer Radical Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? Ann Surg Oncol 2015;22:1032-1042.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.